Addus EVP Blessing sells 527 ADUS shares under plan

Addus HomeCare Corp executive Cliff Donald Blessing reported open-market sales of company stock.

Rhea-AI Filing Summary

Addus HomeCare Corp executive Cliff Donald Blessing reported open-market sales of company stock. He sold 350 shares on February 24 at $107.14 per share and 177 shares on February 25 at $105.36 per share. These transactions were made under a previously established Rule 10b5-1 trading plan to satisfy tax obligations from vesting restricted stock awards. After these sales, he directly owns 12,361 common shares.

Insider Trade Summary

Net Seller: 527 shares

Net Sell 2 txns

Insider BLESSING CLIFF DONALD

Role EVP, Chief Development Officer

Sold 527 shs ($56K)

Type	Security	Shares	Price	Value
Sale	Common Stock	177	$105.36	$19K
Sale	Common Stock	350	$107.14	$37K

Holdings After Transaction: Common Stock — 12,361 shares (Direct)

Footnotes (2)

1. F1. This transaction reflects the sale of shares, made pursuant to a previously established 10b5-1 plan, for the purpose of satisfying tax obligations due upon the vesting of restricted stock awards granted by the Issuer.
2. F2. Adoption date of referenced 10b5-1(c) plan is: 03/14/2025

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transactions did Addus HomeCare (ADUS) report for Cliff Donald Blessing?

Addus HomeCare reported that EVP and Chief Development Officer Cliff Donald Blessing sold a total of 527 common shares in two open-market transactions, executed under a pre-established Rule 10b5-1 trading plan tied to vested restricted stock awards and related tax obligations.

On what dates did the ADUS executive stock sales occur and at what prices?

The reported insider sales occurred on February 24 and February 25, 2026. Blessing sold 350 shares at $107.14 per share on February 24 and 177 shares at $105.36 per share on February 25 in open-market transactions.

How many Addus HomeCare (ADUS) shares does Cliff Donald Blessing hold after these sales?

Following the reported transactions, Cliff Donald Blessing directly owns 12,361 shares of Addus HomeCare common stock. This post-transaction holding reflects his remaining direct equity stake after selling 527 shares pursuant to his Rule 10b5-1 trading plan for tax-related purposes.

Were the ADUS insider stock sales by Cliff Donald Blessing discretionary or pre-planned?

The sales were pre-planned, executed under a previously established Rule 10b5-1 trading plan. According to the disclosure, the purpose of these transactions was to cover tax obligations arising from the vesting of restricted stock awards granted by Addus HomeCare.

What is the stated purpose of the recent insider stock sales at Addus HomeCare (ADUS)?

The filing states the sales were made to satisfy tax obligations due upon the vesting of restricted stock awards. These transactions were executed under a previously adopted Rule 10b5-1(c) plan, indicating they were scheduled in advance rather than opportunistic trades.

When was the Rule 10b5-1 trading plan for the ADUS executive adopted?

The referenced Rule 10b5-1(c) trading plan was adopted on March 14, 2025. The recent open-market sales of Addus HomeCare common stock by Cliff Donald Blessing were executed pursuant to this pre-established plan to handle taxes tied to restricted stock vesting.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 02/26/2026 - 04:33 PM EST Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

BLESSING CLIFF DONALD

(Last) (First) (Middle)

6303 COWBOYS WAY

SUITE 600

(Street)

FRISCO TX 75034

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Addus HomeCare Corp [ ADUS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	EVP, Chief Development Officer

3. Date of Earliest Transaction (Month/Day/Year)
02/24/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	02/24/2026		S(1)(2)		350	D	$107.14	12,538	D
Common Stock	02/25/2026		S(1)(2)		177	D	$105.36	12,361	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. This transaction reflects the sale of shares, made pursuant to a previously established 10b5-1 plan, for the purpose of satisfying tax obligations due upon the vesting of restricted stock awards granted by the Issuer.

2. Adoption date of referenced 10b5-1(c) plan is: 03/14/2025

	/s/ Brian Poff, Attorney-in-Fact for Cliff Donald Blessing	02/26/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.